Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
- November -
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
- 2021 -
2022
-
2023
-
2024
-
2025
November 2021 - 73 products
L
IP
Palonosetron Accord 0,25
mg/5 ml
40.77
60.75
10 %
Injection solution: Palonosetronum
Accord Healthcare AG
●
B / SL / SG
FB
G
L
IP
CI
CM
Rosuvastatin Viatris 5 mg
30
7.12
16.95
10 %
Coated tablets: Rosuvastatinum 5 mg
Mylan Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
CM
Rosuvastatin Viatris 5 mg
105
23.75
42.20
10 %
Coated tablets: Rosuvastatinum 5 mg
Mylan Pharma GmbH
B / SL / SG
FB
G
L
IP
CM
Rosuvastatin Viatris 10 mg
30
8.12
18.05
10 %
Coated tablets: Rosuvastatinum 10 mg
Mylan Pharma GmbH
B / SL / SG
FB
G
L
IP
CM
Rosuvastatin Viatris 10 mg
105
27.08
45.80
10 %
Coated tablets: Rosuvastatinum 10 mg
Mylan Pharma GmbH
B / SL / SG
FB
G
L
IP
CM
Rosuvastatin Viatris 20 mg
30
11.78
29.20
10 %
Coated tablets: Rosuvastatinum 20 mg
Mylan Pharma GmbH
B / SL / SG
FB
G
L
IP
CM
Rosuvastatin Viatris 20 mg
105
39.28
59.05
10 %
Coated tablets: Rosuvastatinum 20 mg
Mylan Pharma GmbH
B / SL / SG
FB
G
IP
CI
Bilastin Spirig HC 20 mg
10
2.25
4.15
10 %
Tablets: Bilastinum 20 mg
Spirig HealthCare AG
D / SL / SG
FB
G
IP
CI
Bilastin Spirig HC 20 mg
30
6.10
11.25
10 %
Tablets: Bilastinum 20 mg
Spirig HealthCare AG
D / SL / SG
FB
G
IP
CI
Bilastin Spirig HC 20 mg
50
9.97
18.40
10 %
Tablets: Bilastinum 20 mg
Spirig HealthCare AG
D / SL / SG
FB
G
IP
CI
Bilastin-Mepha 20 mg
10
2.25
4.15
10 %
Tablets: Bilastinum 20 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Bilastin-Mepha 20 mg
30
6.10
11.25
10 %
Tablets: Bilastinum 20 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Bilastin-Mepha 20 mg
50
9.97
18.40
10 %
Tablets: Bilastinum 20 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Perindopril-Amlodipin-
Mepha Teva 5 mg/5 mg
30
13.21
30.80
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Perindopril-Amlodipin-
Mepha Teva 5 mg/5 mg
90
34.71
54.15
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
Perindopril-Amlodipin-
Mepha Teva 5 mg/10 mg
30
13.21
30.80
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
Perindopril-Amlodipin-
Mepha Teva 10 mg/5 mg
30
13.21
30.80
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
Perindopril-Amlodipin-
Mepha Teva 5 mg/10 mg
90
34.71
54.15
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
Perindopril-Amlodipin-
Mepha Teva 10 mg/5 mg
90
34.71
54.15
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
Perindopril-Amlodipin-
Mepha Teva 10 mg/10 mg
30
13.21
30.80
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
Perindopril-Amlodipin-
Mepha Teva 10 mg/10 mg
90
34.71
54.15
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Isotretinoin Sandoz 5mg
30
6.15
15.95
10 %
Soft capsules: Isotretinoinum 5 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Isotretinoin Sandoz 5mg
100
18.06
36.10
10 %
Soft capsules: Isotretinoinum 5 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
Isotretinoin Sandoz 10mg
30
11.23
28.65
10 %
Soft capsules: Isotretinoinum 10 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
Isotretinoin Sandoz 10mg
100
33.91
53.30
10 %
Soft capsules: Isotretinoinum 10 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
Isotretinoin Sandoz 20mg
30
18.19
36.20
10 %
Soft capsules: Isotretinoinum 20 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
Isotretinoin Sandoz 20mg
100
53.59
74.70
10 %
Soft capsules: Isotretinoinum 20 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
Anidulafungin Accord 100 mg
336.12
381.95
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Anidulafunginum 100 mg
Accord Healthcare AG
A / SL / SG
FB
G
L
IP
CI
Trixeo Aerosphere
5/7.2/160 μg
120
61.59
83.40
10 %
AstraZeneca AG
B / SL
FB
G
L
IP
CI
Trixeo Aerosphere
5/7.2/160 μg
360
184.77
217.35
10 %
AstraZeneca AG
B / SL
FB
G
L
IP
Tysabri 150 mg/ml
2
1548.10
1700.05
10 %
Injection solution in prefilled syringe: Natalizumabum 150 mg/ml
Biogen Switzerland AG
B / SL
FB
G
L
IP
Doptelet 20 mg
10
620.37
691.10
10 %
Coated tablets: Avatrombopagum 20 mg
Swedish Orphan
Biovitrum AG
A / SL
FB
G
L
IP
Doptelet 20 mg
15
930.56
1028.45
10 %
Coated tablets: Avatrombopagum 20 mg
Swedish Orphan
Biovitrum AG
A / SL
FB
G
L
IP
Doptelet 20 mg
30
1861.11
2040.50
10 %
Coated tablets: Avatrombopagum 20 mg
Swedish Orphan
Biovitrum AG
A / SL
FB
G
L
IP
CI
Kerendia 10 mg
28
41.72
61.80
10 %
Coated tablets: Finerenonum 10 mg
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
CI
Kerendia 10 mg
98
146.02
175.20
10 %
Coated tablets: Finerenonum 10 mg
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
Kerendia 20 mg
28
41.72
61.80
10 %
Coated tablets: Finerenonum 20 mg
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
Kerendia 20 mg
98
146.02
175.20
10 %
Coated tablets: Finerenonum 20 mg
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
CI
Ponvory 2 mg
475.08
533.10
10 %
Coated tablets: Ponesimodum 2 mg
Janssen-Cilag AG
B / SL
FB
G
L
IP
Ponvory 20 mg
28
973.28
1074.90
10 %
Coated tablets: Ponesimodum 20 mg
Janssen-Cilag AG
B / SL
FB
G
IP
CI
Minalgin
100 ml
10.25
27.50
10 %
Solution (oral): Metamizolum Natricum Monohydricum 500 mg/ml
Streuli Pharma AG
●
B / SL
FB
G
IP
Emerade 300 ug
0.3 ml
45.56
65.95
10 %
Injektionslösung im Fertigpen: Adrenalinum 300µg / 0.3ml
Curatis AG
B / SL
FB
G
IP
Emerade 500 ug
0.5 ml
45.56
65.95
10 %
Injektionslösung im Fertigpen: Adrenalinum 500µg / 0.5ml
Curatis AG
B / SL
FB
G
IP
Daunoblastin 20 mg
31.10
50.25
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Daunorubicini Hydrochloridum 20 mg
Pfizer AG
A / SL
FB
G
L
IP
Enhertu 100 mg
1551.85
1704.15
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum Deruxtecanum 100 mg
Daiichi Sankyo
(Schweiz) AG
A / SL
FB
G
L
IP
Nexviadyme 100 mg
988.96
1049.55
10 %
poudre pour solution à diluer pour perfusion: Avalglucosidasum Alfa 100 mg
Sanofi-Aventis
(Suisse) SA
A / SL
FB
G
IP
V/S
Ervebo
10
PR
PR
k.A.
MSD Merck Sharp &
Dohme AG
B
FB
G
IP
CI
Merfen Octénidine
30 g
PR
PR
k.A.
Gel: Octenidini Dihydrochloridum 1 mg
VERFORA SA
D
FB
G
IP
Ponvory 3 mg
PR
PR
k.A.
Coated tablets: Ponesimodum 3 mg
Janssen-Cilag AG
B
FB
G
IP
Ponvory 4 mg
PR
PR
k.A.
Coated tablets: Ponesimodum 4 mg
Janssen-Cilag AG
B
FB
G
IP
Ponvory 5 mg
PR
PR
k.A.
Coated tablets: Ponesimodum 5 mg
Janssen-Cilag AG
B
FB
G
IP
Ponvory 6 mg
PR
PR
k.A.
Coated tablets: Ponesimodum 6 mg
Janssen-Cilag AG
B
FB
G
IP
Ponvory 7 mg
PR
PR
k.A.
Coated tablets: Ponesimodum 7 mg
Janssen-Cilag AG
B
FB
G
IP
Ponvory 8 mg
PR
PR
k.A.
Coated tablets: Ponesimodum 8 mg
Janssen-Cilag AG
B
FB
G
IP
Ponvory 9 mg
PR
PR
k.A.
Coated tablets: Ponesimodum 9 mg
Janssen-Cilag AG
B
FB
G
IP
Ponvory 10 mg
PR
PR
k.A.
Coated tablets: Ponesimodum 10 mg
Janssen-Cilag AG
B
FB
G
IP
CM
Rosuvastatin Viatris 40 mg
30
PR
PR
k.A.
Coated tablets: Rosuvastatinum 40 mg
Mylan Pharma GmbH
B
FB
G
IP
CM
Rosuvastatin Viatris 40 mg
105
PR
PR
k.A.
Coated tablets: Rosuvastatinum 40 mg
Mylan Pharma GmbH
B
FB
G
CI
H
Similasan Reisekrankheit
60
PR
PR
k.A.
Tablets: 4 Active Agents
Similasan AG
D
FB
G
IP
CI
Xofluza 2 mg / ml
PR
PR
k.A.
Granulat zur Herstellung einer Suspension zum Einnehmen: Baloxavirum Marboxilum 40 mg
Roche Pharma
(Schweiz) AG
B
FB
G
IP
CI
Emerade 150 ug
0.15 ml
PR
PR
k.A.
Injektionslösung im Fertigpen: Adrenalinum 150µg / 0.15ml
Curatis AG
B
FB
G
IP
CI
Emerade 150 ug
2 x 0.15 ml
PR
PR
k.A.
Injektionslösung im Fertigpen: Adrenalinum 150µg / 0.15ml
Curatis AG
B
FB
G
IP
Emerade 300 ug
2 x 0.3 ml
PR
PR
k.A.
Injektionslösung im Fertigpen: Adrenalinum 300µg / 0.3ml
Curatis AG
B
FB
G
IP
Emerade 500 ug
2 x 0.5 ml
PR
PR
k.A.
Injektionslösung im Fertigpen: Adrenalinum 500µg / 0.5ml
Curatis AG
B
FB
G
IP
Padcev 20 mg
681.24
798.45
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Enfortumabum Vedotinum 20 mg
Astellas Pharma AG
A
FB
G
IP
Padcev 30 mg
1028.09
1189.05
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Enfortumabum Vedotinum 30 mg
Astellas Pharma AG
A
FB
G
IP
Nexviadyme 100 mg
5
PR
PR
k.A.
poudre pour solution à diluer pour perfusion: Avalglucosidasum Alfa 100 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Nexviadyme 100 mg
10
PR
PR
k.A.
poudre pour solution à diluer pour perfusion: Avalglucosidasum Alfa 100 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Esketamin Sintetica 5
mg/ml
10 x 5 ml
PR
PR
k.A.
soluzione iniettabile o per infusione: Esketaminum 5 mg/ml
Sintetica SA
B
FB
G
IP
Esketamin Sintetica 25
mg/ml
10 x 2 ml
PR
PR
k.A.
soluzione iniettabile o per infusione: Esketaminum 25 mg/ml
Sintetica SA
B
FB
G
IP
Esketamin Sintetica 25
mg/ml
10 x 10 ml
PR
PR
k.A.
soluzione iniettabile o per infusione: Esketaminum 25 mg/ml
Sintetica SA
B
FB
G
IP
CI
Merfen Octénidine
30 ml
PR
PR
k.A.
spray pour plaies: Octenidini Dihydrochloridum 1 mg/ml
VERFORA SA
D
FB
G
IP
CI
Merfen Octénidine
100 ml
PR
PR
k.A.
spray pour plaies: Octenidini Dihydrochloridum 1 mg/ml
VERFORA SA
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
